Sri Sai Subramanyam Challa 2021. EVALUATING THE EFFECTIVENESS OF RISK-BASED APPROACHES IN STREAMLINING THE REGULATORY APPROVAL PROCESS FOR NOVEL THERAPIES. Journal of Population Therapeutics and Clinical Pharmacology. 28, 2 (Aug. 2021), 436–448. DOI:https://doi.org/10.53555/jptcp.v28i2.7421.